socalTECH

MAY 10, 2021

Carpinteria-based construction management software developer Procore has set its estimated initial IPO pricing, saying in a filing today that it now expects an initial offering price of betweenn $60.00 and $65.00 The company has applied to list on the NYSE under the symbol PCOR.

Pricing 113

Pricing Software Development Software Capital 113

socalTECH

MARCH 25, 2021

Irvine-based VIZIO priced its IPO last night, saying it will sell 12,250,000 shares of its Class A common stock at a price to the public of $21.00 The price is at the low end of its earlier estimated IPO range of $21.00 VIZIO will start trading this morning on the New York Stock Exchange under the symbol VZIO.

Pricing 113

Pricing Class Capital Company 113

socalTECH

JULY 23, 2021

Irvine-based fitness brand owner Xponential Fitness, which owns such fitness brands as Club Pilates, Pure Barre, and YogaSix, said last night that it has priced its initial public offering (IPO). The company said it is offering up 10,000,000 shares of its Class A stock at a price of $12.00

Pricing 113

Pricing Class Startup Company 113

socalTECH

OCTOBER 29, 2021

Laguna Hills-based dental technology developer Sonendo priced its IPO late last night, saying that it will sell 7,800,000 shares of its common stock at $12.00 per share, which will provide the company total gross proceeds of $93.6M. The company is expected to start trading today on the New York Stock Exchange as SONX.

Pricing 113

Pricing Technology Capital Develop 113

socalTECH

JUNE 11, 2014

La Jolla-based biopharmaceuticals developer Ambrx has set its initial estimated pricing range for its IPO, saying in a filing this morning that it expects to price its IPO at between $12.00 ambrx pricing merger acquisition nasdaq ambx exit biotech lifescience biopharma biopharmaceuticals protein antibody' and $14.00

Pricing 147

Pricing Acquisition Capital Marketing 147

socalTECH

NOVEMBER 14, 2013

Monrovia, California-based Xencor has set the initial offering price for its IPO, saying in a filing Thursday morning that it will offer up 10,700,000 shares of its common stock at $7.00 The IPO price is below its initial estimated offering price, which had been between $14.00 and $16.00 and $16.00 Stafford, III. READ MORE>>.

Pricing 157

Pricing Monrovia Acquisition Marketing 157

socalTECH

JULY 18, 2014

TubeMogul , which develops software to help advertisers with their online video buying, priced its IPO last night, offering up 6,250,000 shares of its common stock at $7.00 tubemogul software digital video advertising merger acquisition exit' The company will starts trading this morning on the NASDAQ Global Select Market as TUBE.

Pricing 147

Pricing Advertising Startup Acquisition 147

socalTECH

APRIL 22, 2019

Los Angeles-based Beyond Meat , which develops plant-based meat products, which look and taste like real meat, has set its IPO pricing range, as its preps to go public. According to Beyond Meat, it expects an initial offering price of between $19.00 and $21.00 The company has applied to list on the Nasdaq Global Market as BYND.

Pricing 113

Pricing Los Angeles Marketing Product 113

socalTECH

AUGUST 4, 2014

San Diego-based Otonomy , which is developing treatments for diseases of the inner and middle ear, set its estimated IPO pricing range Friday. Setting and estimated IPO pricing range is one of the activites which leads up to a company''s IPO, and generally occurs as the company embarks on a road show to insitutional investors.

Pricing 147

Pricing Avalon San Diego Acquisition 147

socalTECH

JUNE 26, 2014

Action sports camera maker GoPro priced its IPO at $24.00 The company priced its IPO at the high end of its estimated initial IPO range, which was between $21.00 gopro camera action sports merger acquisition exit electronics hardware consumer' per share, and will start trading today on the NASDAQ Global Market as GPRO.

Pricing 157

Pricing Steamboat Ventures San Diego Southern California 157

socalTECH

JUNE 11, 2021

La Jolla-based biopharmaceuticals startup Janux Therapeutics said early this morning that it has priced its IPO, offering up 11,400,000 shares of its common stock at $17.00 The company begins trading this morning on the Nasdaq Global market under the ticker symbol JANX.

Pricing 113

Pricing Avalon Capital Marketing 113

socalTECH

DECEMBER 3, 2013

Monrovia-based biopharmaceuticals developer Xencor said this morning that it has priced its IPO, at $5.50 xencor biopharma biopharmaceuticals merger acquisition exit lifescience' per share, and will start trading today on the NASDAQ Global Market as XNCR. Xencor sold 12,730,000 shares of its common stock in the IPO. READ MORE>>.

Pricing 138

Pricing Monrovia Acquisition Marketing 138

socalTECH

MARCH 14, 2014

San Diego-based precision medicine developer Ignyta has priced its IPO, saying last night that it is offering up 5,245,000 shares of its common stock at $9.15 ignyta biotech lifescience merger acquisition cancer' The IPO will raised $48.0M for the company. Ignyta will trade on the NASDAQ Capital Market as RXDX, starting today.

Pricing 138

Pricing San Diego Startup Acquisition 138

socalTECH

APRIL 8, 2021

Long Beach-based Agilon Health, which operates a network of physicians focused on Medicare patients, has set its IPO pricing range, saying it hopes to sell 46,600,000 shares of its common stock at between $20.00 and $23.00 The company's IPO could raise as much as $1.232 billion for the company.

Pricing 113

Pricing Long Beach Networking Capital 113

socalTECH

SEPTEMBER 14, 2020

Santa Monica-based GoodRx , a developer of a digital healthcare and prescriptions service, has set an IPO pricing range of between $24.00 and $28.00 The company is looking to raise as much as $1.1 billion through its IPO on the NASDAQ Global Select Market. GoodRx has filed to trade as GDRX.

Silver Lake 113

Silver Lake Pricing Santa Monica Equity 113

socalTECH

SEPTEMBER 27, 2016

Carlsbad-based Obalon Therapeutics , which is developing a balloon-based medical device for assisting in weight loss, has set the estimated initial IPO pricing range for its public offering, saying it now expects an initial public offering at between $14.00 if it prices at the high end of its estimated range. and $16.00

Pricing 100

Pricing Southern California .Net Venture Capital 100

socalTECH

FEBRUARY 5, 2014

La Jolla-based biopharmaceuticals developer Auspex Pharmaceuticals has priced its IPO, saying it will offer up 7,000,000 shares of its common stock at $12.00 auspex pharmaceuticals merger acquisition lifescience healthcare huntington movement disorder tourette tardive dyskinesia' Baird & Co., READ MORE>>.

Pricing 138

Pricing Acquisition Capital Marketing 138

socalTECH

JUNE 8, 2020

La Jolla-based Avidity Biosciences , which is developing oligonucleotide-based therapies for rare and serious diseases, has set the pricing range for its IPO, saying it is looking to sell 10 million shares at between $14.00 and $16.00 The company said it has applied to list on the Nasdaq Global Market as RNA.

Pricing 113

Pricing Capital Invest Marketing 113

socalTECH

JANUARY 17, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 and $16.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. as early as Thursday.

Pricing 100

Pricing Avalon Southern California Venice 100

socalTECH

DECEMBER 7, 2017

San Diego-based Odonate Therapeutics , a pharmaceuticals startup focused on chemotherapy drugs, has priced its IPO, saying on Wednesday afternoon that it has priced its IPO at $24.00 per share was on the low end of its initial estimated pricing range of $24.00 The $24.00

Pricing 113

Pricing San Diego Capital Funding 113

Tech.Co

FEBRUARY 19, 2021

Many have seen the acquisition as an attempt to fight back against Shopify's rampant growth during the coronavirus pandemic. The Amazon/Selz Acquisition. Selz currently offers three monthly pricing plans which allow you to create your own store using its platform, or attach Selz' smarts to an existing site. Test Score. .

News 137

News Acquisition Platform Sales 137

socalTECH

NOVEMBER 4, 2013

Monrovia, California-based Xencor , the biopharmaceuticals technology developer headed by Bassil Dahiyat, has set its IPO pricing range, saying today in a regulatory filing that it is expecting to price its IPO at between $14.00 xencor biopharma biopharmaceuticals merger acquisition exit' and $16.00 Stafford, III. READ MORE>>.

Pricing 138

Pricing Monrovia Acquisition Marketing 138

socalTECH

MARCH 16, 2021

The company said it expects its initial offering price to be between $21.00 Irvine-based tellevision and display maker VIZIO says it has launched its IPO roadshow this morning, looking to sell 15,120,000 shares of its Class A common stock. and $23.00 The company is looking to list on the New York Stock Exchange under the symbol VZIO.

Pricing 113

Pricing Class Capital Company 113

socalTECH

MAY 16, 2013

San Diego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 Ambit priced well below its estimated initial public offering range, which had been set at between $13.00 ambit biosciences lifescience merger acquisition' and $15.00 READ MORE>>.

Pricing 138

Pricing San Diego Startup Acquisition 138

socalTECH

NOVEMBER 14, 2013

San Diego-based medical device manufacturer Tandem Diabetes Care priced its IPO last night, saying it will offer up 8,000,000 shares of its common stock at $15.00 tandem diabetes care diabetic medical device exit merger acquisition tndm' READ MORE>>.

Pricing 153

Pricing San Diego Startup Acquisition 153

Berkonomics

JANUARY 26, 2017

The rest of the purchase price was concocted from a brew of zero coupon bonds (where the face value is many times the invested amount until the reduced cost bonds mature thirty years later), and borrowing using the target company’s accounts receivable and other assets as collateral for a loan to purchase the company. What power!

Pricing 120

Pricing Sales Tool Equity 120

socalTECH

APRIL 4, 2017

San Diego-based Tocagen , a clinical stage gene therapy company aiming at treating cancer, has set the pricing range for its IPO. The company said in a filing that it expects to offer 7,250,000 shares of its common stock at between $10.00 and $12.00 The company has applied to list as TOCA on the NASDAQ Global Market.

Pricing 160

Pricing San Diego Marketing Company 160

socalTECH

OCTOBER 25, 2013

Aerie Pharmaceuticals , which develops therapies for treating glaucoma and other eye diseases, has priced its IPO, saying this morning that it is offering up 6,720,000 share os its common stock at $10.00 aerie pharmaceuticals merger acquisition exit lifescience glaucoma' Aerie had filed for an IPO last month. READ MORE>>.

Pricing 138

Pricing Research Acquisition Marketing 138

socalTECH

APRIL 25, 2013

San Diego-based biopharmaceuticals developer Receptos has set the initial, estimated pricing range for its IPO, saying in a filing Thursday that it now expects its IPO pricing to be between $14.00 receptos merger acquisition lifescience biopharma biopharmaceuticals rcpt exit' and $16.00 READ MORE>>.

Pricing 153

Pricing San Diego Acquisition Funding 153

socalTECH

MAY 29, 2019

CrowdStrike , the cybersecurity software developer which has a significant research and development presence in Irvine, has set its IPO pricing range, saying on Wednesday that it looking to sell 18,000,000 shares of its common stock at between $19.00 and $23.00 The company has applied to list as CRWD on the Nasdaq Global Select Market.

Pricing 113

Pricing Research Software Development Capital 113

socalTECH

JULY 23, 2018

Santa Barbara-based Sonos , the developer of user-friendly, Internet-connected, whole-home audio systems, set its estimated IPO pricing range on Monday morning, the next step in bringing the company to market. According to its updated S-1 filing, Sonos is looking to sell 13,888,888 shares of its common stock at between $17.00 and $19.00

Pricing 100

Pricing Santa Barbara Redpoint Marketing 100

socalTECH

JULY 15, 2010

Los Angeles-based 3D movie technology provider RealD said late Thursday evening that it has priced its IPO, offering 12.5M The IPO priced above the firm's initial estimated IPO pricing of between $13.00 Tags: reald merger acquisition content movie hollywood. shares of its common stock at $16.00 and $15.00 READ MORE>>.

Pricing 178

Pricing Hollywood Startup Content 178

SoCal CTO

MARCH 1, 2010

Startup Killer: the Cost of Customer Acquisition | For Entrepreneurs , February 2, 2010 Looks at the critical equation around customer acquisition cost vs. customer lifetime value similar to what I discussed in Startup Metrics but in more depth. Great stuff. This post looks at the implementation details of HTML 5 video.

Pricing 150

Pricing Acquisition Customer Custom 150

socalTECH

JULY 9, 2010

Monrovia-based Green Dot , the provider of prepaid debit cards, has set pricing on its IPO, saying in a filing Friday that it estimates and initial public offering price of between $32.00 Tags: green financial merger acquisition. and $35.00 READ MORE>>.

Pricing 213

Pricing Tech Coast Angels Monrovia .Net 213

socalTECH

APRIL 1, 2015

GoDaddy , the provider of Internet domain name and related hosting services--and which has a significant LA presence due to its ownership of LA''s Media Temple --priced its IPO late Tuesday evening at $20.00 The price is above its initial estimated pricing range of $17.00 godaddy merger acquisition mediatemple russ reeder'

Silver Lake 100

Silver Lake Pricing Technical Review Media 100

socalTECH

MAY 25, 2016

Culver City-based NantHealth , one of the startups out of billionaire Patrick Soon-Shiong's NantWorks portfolio, has set its IPO pricing range at between $12.50 The next step in the IPO process is the company's roadshow to investors and actual pricing of an IPO. and $15.50 per share, the company said in a regulatory filing on Tuesday.

Pricing 113

Pricing Culver City Marketing Startup 113

socalTECH

JUNE 27, 2017

NantCell said the price is a "significant premium" to recent equity financings. Soon-Shiong and NantCell recently was sued by investors over the "lowball" initial pricing on the deal. According to NantCell, it will pay $2.00 in cash or NantCell common stock for each share of Altor BioScience stock, with an additional $4.00

Culver City 113

Culver City Acquisition Pricing Equity 113